A very interesting study published by your group (Annals of Emergency Medicine, 2008) showed that a singular procalcitonin value in the ED outperformed classical clinical rules for CAP (PSI or CURB-65) in predicting 30-day mortality, specifically in high-risk patients. In ProACT, there was a relationship between procalcitonin tier and ICU admission (and SIRS, as has been mentioned before) shown in Table S3. Finally, although this study did not show differences in mortality between procalcitonin tiers, it was not powered for it in the first place.
Adding another factor to such tools might turn out to be cost-ineffective, but literature about it is growing. I wonder about a particular situation evidenced by the authors in the above article: high risk predicting tools (i.e., PSI IV-V) and procalcitonin <0.1. Pardon the lack of specific context but, could that change our approach to that particular patient?
Easy one-click social registrationIs this safe?
We only receive the minimum information necessary to verify your account. We never get access to your friends/contacts or your profile, and we never post on your behalf. Your social account is used for logging in only.ORRegister via email
Send me updates on this Contest
In order to ensure a fair voting process and to make sure that no one votes more than once, we ask that you register either with a social networking account (easiest, only requires one click) or by registering with your email address (this will require you to click on a verification email that we will send you).
You only need to register once.